We estimated the cumulative incidence of persistent infection and the proportion of CIN/AIS attributable to individual carcinogenic HPV genotypes , as well as the proportion of CIN/AIS lesions potentially preventable by a prophylactic @-valent HPV@/@/@ / @/@/@ / @/@/@ vaccine .